Ditchcarbon
  • Contact
  1. Organizations
  2. Personalis
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 8 months ago

Personalis Sustainability Profile

Company website

Personalis, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in precision medicine, focusing on advanced genomic sequencing and analysis services. Personalis offers unique solutions, including its proprietary NeXT Personalised Medicine platform, which integrates comprehensive genomic data to provide tailored insights for cancer treatment and research. This innovative approach sets Personalis apart in a competitive market, enabling healthcare providers to make informed decisions based on individual patient profiles. With a strong market position, Personalis has achieved notable milestones, including partnerships with major pharmaceutical companies and contributions to significant clinical trials, solidifying its reputation as a trusted leader in the field of personalised genomics.

DitchCarbon Score

How does Personalis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Personalis's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Personalis's reported carbon emissions

As of the latest available data, Personalis, Inc., headquartered in the United States, does not report specific carbon emissions figures. However, the company is committed to reducing its carbon footprint and has set near-term targets as part of its climate strategy. Personalis is classified under the Pharmaceuticals, Biotechnology, and Life Sciences sector and has committed to near-term targets, although specific reduction percentages or timelines have not been disclosed. The company is actively engaged in sustainability initiatives, reflecting a broader commitment to environmental responsibility. It is important to note that Personalis does not inherit emissions data from any parent or related organizations, indicating that its climate commitments are independently established. The company is focused on aligning its operations with industry standards for climate action, although detailed emissions data and long-term targets are currently unavailable.

How Carbon Intensive is Personalis's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Personalis's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Personalis's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Personalis is in US, which has a low grid carbon intensity relative to other regions.

Personalis's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Personalis has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Personalis's Emissions with Industry Peers

GRAIL, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Invitae Corporation

US
•
Other business services (74)
Updated 14 days ago

Geneseeq Technology Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bio Rad

US
•
Research and development services (73)
Updated 14 days ago

Cardiff Oncology, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Strata Oncology, Inc.

US
•
Health and social work services (85)
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy